BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei W, Ni D, Ehlerding EB, Luo QY, Cai W. PET Imaging of Receptor Tyrosine Kinases in Cancer. Mol Cancer Ther 2018;17:1625-36. [PMID: 30068751 DOI: 10.1158/1535-7163.MCT-18-0087] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Melendez-alafort L, Ferro-flores G, De Nardo L, Ocampo-garcía B, Bolzati C. Zirconium immune-complexes for PET molecular imaging: Current status and prospects. Coordination Chemistry Reviews 2023;479:215005. [DOI: 10.1016/j.ccr.2022.215005] [Reference Citation Analysis]
2 Buller DM, Antony M, Ristau BT. Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction. Onco Targets Ther 2023;16:49-64. [PMID: 36718243 DOI: 10.2147/OTT.S393296] [Reference Citation Analysis]
3 Rbah-vidal L. Immuno-PET as a Tool for Cancer Detection and Monitoring Response to Treatments. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_359-1] [Reference Citation Analysis]
4 Wei W, Zhang D, Zhang Y, Li L, Jin Y, An S, Lv C, Zhao H, Wang C, Huang Y, Dong J, Huang G, Liu J. Development and comparison of (68)Ga/(18)F/(64)Cu-labeled nanobody tracers probing Claudin18.2. Mol Ther Oncolytics 2022;27:305-14. [PMID: 36570796 DOI: 10.1016/j.omto.2022.11.003] [Reference Citation Analysis]
5 Castello A, Castellani M, Florimonte L, Ciccariello G, Mansi L, Lopci E. PET radiotracers in glioma: a review of clinical indications and evidence. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00523-7] [Reference Citation Analysis]
6 Wang Q, Zhang X, Wei W, Cao M. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective. Mol Pharm 2022. [PMID: 35771950 DOI: 10.1021/acs.molpharmaceut.2c00353] [Reference Citation Analysis]
7 A.a. Kayode A, Eya IE, Kayode OT. A short review on cancer therapeutics. Physical Sciences Reviews 2022;0. [DOI: 10.1515/psr-2021-0169] [Reference Citation Analysis]
8 Wu Q, Huang G, Wei W, Liu J. Molecular Imaging of Renal Cell Carcinoma in Precision Medicine. Mol Pharm 2022. [PMID: 35510710 DOI: 10.1021/acs.molpharmaceut.2c00034] [Reference Citation Analysis]
9 Jin C, Luo X, Li X, Zhou R, Zhong Y, Xu Z, Cui C, Xing X, Zhang H, Tian M. Positron emission tomography molecular imaging-based cancer phenotyping. Cancer 2022. [PMID: 35417604 DOI: 10.1002/cncr.34228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nerella SG, Singh P, Sanam T, Digwal CS. PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective. Front Med (Lausanne) 2022;9:812270. [PMID: 35295604 DOI: 10.3389/fmed.2022.812270] [Reference Citation Analysis]
11 Chegu A, Panikar SS, Pereira PM. Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.03.004] [Reference Citation Analysis]
12 Kip A, Heskamp S. Antibodies and antibody constructs as radiopharmaceuticals. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00009-0] [Reference Citation Analysis]
13 Wei W, Zhang D, Wang C, Zhang Y, An S, Chen Y, Huang G, Liu J. Annotating CD38 Expression in Multiple Myeloma with [18F]F-Nb1053. Mol Pharm 2021. [PMID: 34846151 DOI: 10.1021/acs.molpharmaceut.1c00733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH. Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. Mol Imaging Biol 2021. [PMID: 34231102 DOI: 10.1007/s11307-021-01620-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Borm FJ, Smit J, Oprea-Lager DE, Wondergem M, Haanen JBAG, Smit EF, de Langen AJ. Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy. Cancers (Basel) 2021;13:3083. [PMID: 34205572 DOI: 10.3390/cancers13123083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Masłowska K, Halik PK, Tymecka D, Misicka A, Gniazdowska E. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy. Cancers (Basel) 2021;13:1072. [PMID: 33802353 DOI: 10.3390/cancers13051072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kaufman NEM, Dhingra S, Jois SD, Vicente MDGH. Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). Molecules 2021;26:1076. [PMID: 33670650 DOI: 10.3390/molecules26041076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
18 Wang C, Chen Y, Hou YN, Liu Q, Zhang D, Zhao H, Zhang Y, An S, Li L, Hou J, Huang G, Liu J, Zhao YJ, Wei W. ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053. Eur J Nucl Med Mol Imaging 2021;48:2749-60. [PMID: 33543326 DOI: 10.1007/s00259-021-05218-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
19 Krasniqi A, Xavier C, Devoogdt N. Newer Bioconjugation Methods. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00030-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC. PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro Oncol 2019;21:585-95. [PMID: 30615138 DOI: 10.1093/neuonc/noz003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 29.3] [Reference Citation Analysis]
21 Pereira PMR, Norfleet J, Lewis JS, Escorcia FE. Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition. J Nucl Med 2021;62:366-71. [PMID: 32646879 DOI: 10.2967/jnumed.120.244897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wei W, Liu Q, Jiang D, Zhao H, Kutyreff CJ, Engle JW, Liu J, Cai W. Tissue Factor-Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer. Adv Sci (Weinh) 2020;7:1903595. [PMID: 32670751 DOI: 10.1002/advs.201903595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
23 Garousi J, Orlova A, Frejd FY, Tolmachev V. Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond. EJNMMI Radiopharm Chem 2020;5:16. [PMID: 32577943 DOI: 10.1186/s41181-020-00094-w] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
24 Wei W, Jiang D, Lee HJ, Li M, Kutyreff CJ, Engle JW, Liu J, Cai W. Development and characterization of CD54-targeted immunoPET imaging in solid tumors. Eur J Nucl Med Mol Imaging 2020;47:2765-75. [PMID: 32279097 DOI: 10.1007/s00259-020-04784-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
25 Werner JM, Lohmann P, Fink GR, Langen KJ, Galldiks N. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors. Molecules 2020;25:E1471. [PMID: 32213992 DOI: 10.3390/molecules25061471] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
26 Salvatore B, Caprio MG, Hill BS, Sarnella A, Roviello GN, Zannetti A. Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer. Cancers (Basel) 2019;11:E1614. [PMID: 31652624 DOI: 10.3390/cancers11101614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnology 2019;17:90. [PMID: 31434562 DOI: 10.1186/s12951-019-0524-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
28 Vorobyeva A, Schulga A, Konovalova E, Güler R, Löfblom J, Sandström M, Garousi J, Chernov V, Bragina O, Orlova A, Tolmachev V, Deyev SM. Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3. Sci Rep 2019;9:9405. [PMID: 31253840 DOI: 10.1038/s41598-019-45795-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
29 Wei W, Jiang D, Ehlerding EB, Barnhart TE, Yang Y, Engle JW, Luo QY, Huang P, Cai W. CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma. Adv Sci (Weinh) 2019;6:1801237. [PMID: 31065511 DOI: 10.1002/advs.201801237] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
30 Ni D, Ferreira CA, Barnhart TE, Quach V, Yu B, Jiang D, Wei W, Liu H, Engle JW, Hu P, Cai W. Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. J Am Chem Soc 2018;140:14971-9. [PMID: 30336003 DOI: 10.1021/jacs.8b09374] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 19.8] [Reference Citation Analysis]